Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Opendoor Technologies Inc (OPEN) Price & Performance

Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.

The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.

Opendoor Technologies (OPEN) trades at $2.11, down 86% from its peak, with bearish technical signals and mixed quarterly earnings. The company shows declining revenue from $15.6B in 2022 to $4.4B in 2025, with persistent net losses widening to -$1.3B. Recent news highlights mortgage expansion to 35-40 states by end-2026 and a $100,000 insider purchase by the CEO, while housing market volatility and rate hike concerns pressure the stock.

The outlook remains challenged by high debt, negative margins, and housing sector headwinds, but analyst consensus targets $4.92 imply 133% upside. Key risks include execution on profitability, interest rate sensitivity, and competitive pressures. The stock's deep valuation discount (P/S 0.54) offers potential if operational turnaround succeeds.